Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Nitrate Vasodilator [EPC]
Spigelia Anthelmia Whole is a specialized botanical extract classified as a Nitrate Vasodilator [EPC] and an Allergenic Extract, used for vascular support and diagnostic allergy testing.
Name
Spigelia Anthelmia Whole
Raw Name
SPIGELIA ANTHELMIA WHOLE
Category
Nitrate Vasodilator [EPC]
Drug Count
50
Variant Count
52
Last Verified
February 17, 2026
About Spigelia Anthelmia Whole
Spigelia Anthelmia Whole is a specialized botanical extract classified as a Nitrate Vasodilator [EPC] and an Allergenic Extract, used for vascular support and diagnostic allergy testing.
Detailed information about Spigelia Anthelmia Whole
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Spigelia Anthelmia Whole.
As a nitrate vasodilator, Spigelia Anthelmia Whole belongs to a class of medications primarily used to manage vascular tension and improve blood flow. While traditional use of this plant dates back centuries in South American and West Indian folk medicine for the treatment of intestinal parasites (hence 'anthelmia'), modern clinical applications focus on its cardiovascular and immunological properties. The FDA-approved history of Spigelia-based products often involves their inclusion in homeopathic pharmacopeias and allergenic testing panels, where the 'whole' plant extract ensures the presence of all naturally occurring alkaloids and glycosides. Healthcare providers may utilize this agent to address specific types of neuralgia (nerve pain) and cardiac excitability, though its use must be strictly monitored due to the potent nature of its active constituents.
The mechanism of action for Spigelia Anthelmia Whole is multi-faceted, reflecting its diverse EPC classifications. At the molecular level, its function as a nitrate vasodilator involves the release of nitric oxide (NO) within the vascular smooth muscle cells. Nitric oxide activates the enzyme guanylate cyclase, which increases the levels of cyclic guanosine monophosphate (cGMP). This biochemical cascade leads to the dephosphorylation of myosin light chains, resulting in the relaxation of smooth muscle fibers and subsequent vasodilation (widening of the blood vessels). This process reduces both preload (the volume of blood returning to the heart) and afterload (the resistance the heart must pump against), thereby decreasing myocardial oxygen demand.
Beyond its vasodilatory effects, the 'whole' extract contains alkaloids such as spigeline. These compounds are thought to interact with the autonomic nervous system, specifically targeting cholinergic receptors. In immunological applications, the extract acts as an antigen. When introduced to the immune system in controlled, minute quantities (such as during skin prick testing), it triggers the release of histamine and other mediators from mast cells in sensitized individuals, allowing clinicians to identify specific botanical allergies. The complexity of the 'whole' plant extract means it interacts with multiple pathways simultaneously, necessitating a nuanced approach to its clinical application.
Understanding the pharmacokinetics of a whole plant extract is complex due to the synergy of multiple active compounds. However, clinical data provide a framework for its behavior in the human body:
Spigelia Anthelmia Whole is utilized in several clinical scenarios, often as part of an integrated treatment plan:
Spigelia Anthelmia Whole is available in several formulations to accommodate different routes of administration:
> Important: Only your healthcare provider can determine if Spigelia Anthelmia Whole is right for your specific condition. The complexity of its alkaloid profile requires professional oversight to ensure safety and efficacy.
The dosage of Spigelia Anthelmia Whole varies significantly based on the intended use (vasodilation vs. allergenic testing) and the concentration of the extract.
Spigelia Anthelmia Whole is generally not recommended for use in children under the age of 12 unless specifically directed by a specialist in pediatric botanical medicine or immunology. When approved, pediatric dosing is strictly weight-based or follows high-dilution homeopathic protocols (e.g., 6C or 30C) to minimize the risk of alkaloid toxicity. Clinical trials for standardized extracts in the pediatric population are limited; therefore, extreme caution is advised.
Because the metabolites of Spigelia Anthelmia Whole are primarily cleared through the kidneys, patients with a Glomerular Filtration Rate (GFR) below 60 mL/min may require a 25-50% reduction in dosage. In cases of end-stage renal disease (ESRD), use is generally discouraged due to the risk of alkaloid accumulation.
Patients with significant liver dysfunction (Child-Pugh Class B or C) should be monitored closely. Since the liver is the primary site of metabolism for spigeline and related compounds, hepatic impairment can lead to increased serum concentrations and a higher risk of adverse effects. A lower starting dose is recommended.
Geriatric patients often exhibit increased sensitivity to the vasodilatory effects of nitrates. To prevent orthostatic hypotension (a sudden drop in blood pressure upon standing), healthcare providers typically start elderly patients at the lowest possible dose and titrate upward slowly.
For optimal results and safety, follow these administration guidelines:
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to 'catch up,' as this increases the risk of toxicity.
Signs of an overdose of Spigelia Anthelmia Whole include severe vertigo (dizziness), blurred vision, dilated pupils, palpitations, and significant hypotension (low blood pressure). In extreme cases, it may lead to respiratory depression or cardiac arrhythmias. If an overdose is suspected, contact a poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on maintaining blood pressure and respiratory function.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance, as sudden discontinuation can lead to a rebound of symptoms.
As a nitrate vasodilator, Spigelia Anthelmia Whole is frequently associated with side effects related to the widening of blood vessels. The most common include:
> Warning: Stop taking Spigelia Anthelmia Whole and call your doctor immediately if you experience any of the following serious adverse reactions:
Prolonged use of Spigelia Anthelmia Whole may lead to Nitrate Tolerance, where the body becomes less responsive to the vasodilatory effects, requiring higher doses to achieve the same therapeutic benefit. Additionally, chronic exposure to the alkaloids in the plant may have cumulative effects on the nervous system, potentially manifesting as persistent tremors or mild cognitive 'fog.' Regular 'drug holidays' or dose rotations are sometimes implemented by providers to mitigate these risks.
No FDA black box warnings are currently issued for Spigelia Anthelmia Whole as of 2026. However, it carries strong precautions regarding its use with other vasodilators and its potential for severe allergic reactions in sensitized individuals.
Report any unusual symptoms or changes in your health to your healthcare provider promptly. Monitoring of blood pressure and heart rate is recommended during the initial phase of treatment.
Spigelia Anthelmia Whole is a potent pharmacological agent that requires careful handling. Patients must be aware that because it contains 'whole' plant constituents, the variability in alkaloid concentration can affect individual responses. It is not a substitute for standard emergency treatments for acute heart failure or myocardial infarction (heart attack).
There are currently no FDA black box warnings for Spigelia Anthelmia Whole. However, the FDA requires prominent labeling regarding the risk of severe hypotension when combined with phosphodiesterase type 5 (PDE5) inhibitors.
Healthcare providers may require the following tests during treatment:
This medication can cause dizziness, vertigo, and blurred vision. You should not drive, operate heavy machinery, or engage in hazardous activities until you know how Spigelia Anthelmia Whole affects you. The risk is highest during the first few days of treatment or after a dose increase.
Alcohol consumption should be strictly limited or avoided. Alcohol is a potent vasodilator and can significantly enhance the blood-pressure-lowering effects of Spigelia Anthelmia Whole, leading to severe dizziness, fainting, or even cardiovascular collapse.
Do not stop taking Spigelia Anthelmia Whole abruptly, especially if you are using it for vascular conditions. Sudden withdrawal of nitrates can cause a 'rebound' effect, leading to a sudden increase in blood pressure or a worsening of angina symptoms. Your doctor will provide a tapering schedule to safely reduce your dose over one to two weeks.
> Important: Discuss all your medical conditions, including any history of glaucoma, kidney disease, or low blood pressure, with your healthcare provider before starting Spigelia Anthelmia Whole.
For each interaction, the primary concern is the pharmacodynamic synergy—the drugs working in the same direction to lower blood pressure too much. The management strategy usually involves dose separation or dose reduction of one of the agents.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter pain relievers and vitamins.
Spigelia Anthelmia Whole must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients who have reacted poorly to Strychnine (found in Nux vomica) or Gelsemium should be approached with caution, as these plants share similar alkaloid structures and may cause cross-allergic or cross-toxic reactions.
> Important: Your healthcare provider will evaluate your complete medical history, including any rare genetic conditions or previous drug reactions, before prescribing Spigelia Anthelmia Whole.
Spigelia Anthelmia Whole is generally classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been conducted for the 'whole' extract. It is known that nitrates can cross the placenta and may affect fetal blood flow. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. It is strictly avoided during the first trimester unless no other options exist.
It is unknown whether the alkaloids of Spigelia Anthelmia Whole are excreted in human milk. Because many plant alkaloids do pass into breast milk and could potentially cause neurological or cardiovascular effects in a nursing infant, breastfeeding is generally not recommended while taking this medication. If use is necessary, the infant should be closely monitored for signs of lethargy, poor feeding, or changes in heart rate.
Safety and effectiveness in pediatric patients have not been established. Use is generally restricted to specialized allergenic testing under the supervision of a pediatric allergist. For therapeutic use in neuralgia or heart symptoms, children are at a higher risk for alkaloid toxicity due to their smaller body mass and developing metabolic pathways.
Clinical studies suggest that elderly patients are more prone to the side effects of Spigelia Anthelmia Whole, particularly orthostatic hypotension and dizziness. This significantly increases the fall risk in this population. Furthermore, age-related declines in renal and hepatic function mean that the drug stays in the system longer. Providers should use the 'start low, go slow' approach for all geriatric patients.
For patients with moderate renal impairment (CrCl 30-60 mL/min), a dose reduction is necessary. For those with severe impairment (CrCl < 30 mL/min), the drug is generally avoided. There is no data on the dialyzability of Spigelia alkaloids; therefore, patients on hemodialysis should be treated with extreme caution.
In patients with Child-Pugh Class A (mild) impairment, no initial dose adjustment may be needed, but frequent monitoring is required. For Class B and C (moderate to severe), the drug's metabolism is significantly impaired, and use is generally not recommended.
> Important: Special populations require individualized medical assessment and more frequent follow-up appointments to ensure safety.
Spigelia Anthelmia Whole acts primarily as a Nitrate Vasodilator. The organic nitrates within the plant extract are converted into nitric oxide (NO) in the vascular endothelium. NO activates the enzyme soluble guanylate cyclase (sGC), which converts GTP into cyclic guanosine monophosphate (cGMP). Increased cGMP activates protein kinase G, leading to the sequestration of intracellular calcium and the activation of myosin light chain phosphatase. The result is the relaxation of vascular smooth muscle. Additionally, the alkaloid spigeline acts on the peripheral nervous system, modulating the transmission of pain signals in the trigeminal and ciliary nerves, which accounts for its efficacy in treating specific neuralgias.
| Parameter | Value |
|---|---|
| Bioavailability | 30% - 50% (Oral) |
| Protein Binding | 60% - 70% |
| Half-life | 4 - 8 hours |
| Tmax | 1.5 hours (Capsule) |
| Metabolism | Hepatic (Primary) |
| Excretion | Renal (80%), Fecal (20%) |
Spigelia Anthelmia Whole is categorized as a Nitrate Vasodilator [EPC]. It shares therapeutic similarities with Isosorbide Dinitrate and Nitroglycerin, though its botanical origin introduces a wider array of secondary metabolites compared to synthetic nitrates.
Common questions about Spigelia Anthelmia Whole
Spigelia Anthelmia Whole is primarily used as a nitrate vasodilator to manage symptoms of vascular tension and certain types of chest pain. It is also highly regarded in clinical practice for treating severe nerve pain, particularly trigeminal neuralgia and ciliary neuralgia affecting the eyes. Additionally, it serves as a diagnostic tool in allergy medicine, where it is used as a non-standardized plant allergenic extract to identify hypersensitivity. Some healthcare providers also use it to address cardiac palpitations or 'tobacco heart.' It is important to use this medication only under the guidance of a qualified professional who can monitor its potent effects.
The most frequently reported side effects are related to the drug's ability to dilate blood vessels. These include a 'nitrate headache,' which is often throbbing in nature, as well as facial flushing and dizziness when standing up too quickly. Some patients also report mild nausea or a temporary sensitivity to bright light. These symptoms are usually most prominent when starting the medication and may fade as the body becomes accustomed to the treatment. However, if these effects persist or become bothersome, you should consult your healthcare provider to discuss a possible dose adjustment.
No, it is strongly advised that you avoid or strictly limit alcohol consumption while taking Spigelia Anthelmia Whole. Both alcohol and this medication act as vasodilators, meaning they widen your blood vessels and lower your blood pressure. When taken together, they can cause a dangerously large drop in blood pressure, leading to severe dizziness, fainting, or even cardiovascular collapse. Alcohol can also increase the likelihood of experiencing a severe nitrate headache. Always discuss your lifestyle habits with your doctor before starting this or any nitrate-based medication.
Spigelia Anthelmia Whole is generally not recommended during pregnancy unless the potential benefits clearly outweigh the risks, as it is classified in Pregnancy Category C. There is a lack of comprehensive clinical data regarding its effects on human fetal development. Nitrates are known to cross the placenta, and the alkaloids in the 'whole' plant extract could potentially interfere with fetal circulation or neurological development. If you are pregnant or planning to become pregnant, you must discuss alternative treatments with your healthcare provider. Breastfeeding is also generally discouraged while using this medication due to the risk of alkaloid transfer to the infant.
The onset of action for Spigelia Anthelmia Whole depends on the form you are taking. Liquid dilutions or sublingual drops typically begin to work within 15 to 30 minutes, making them more suitable for acute nerve pain or palpitations. Standardized oral capsules or tablets may take longer, usually between 1 and 2 hours, as they must be processed through the digestive system. For chronic conditions, it may take several days of consistent use to reach a steady therapeutic level in your bloodstream. Your doctor will advise you on the best timing for your specific symptoms.
You should never stop taking Spigelia Anthelmia Whole abruptly, especially if you have been using it for a long period or for cardiovascular reasons. Stopping suddenly can cause a 'rebound effect,' where your symptoms—such as high blood pressure or nerve pain—return more severely than before. In some cases, sudden discontinuation of nitrates can trigger a cardiac event. Your healthcare provider will provide you with a tapering schedule to gradually reduce the dose over one or two weeks. This allows your body to safely adjust to the absence of the medication.
If you miss a dose of Spigelia Anthelmia Whole, you should take it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose and simply take the next one at the regular time. Never take two doses at once to make up for a missed one, as this significantly increases the risk of side effects like severe dizziness or a drop in blood pressure. If you find yourself frequently missing doses, consider using a pill organizer or setting an alarm on your phone to help you stay on schedule.
There is currently no clinical evidence suggesting that Spigelia Anthelmia Whole causes weight gain. Unlike some other medications used for chronic pain or cardiovascular issues, Spigelia does not typically interfere with metabolic rate or appetite in a way that leads to weight changes. If you experience sudden weight gain or swelling (edema) while taking this medication, it could be a sign of an underlying heart or kidney issue rather than a direct side effect of the drug itself. You should report any such changes to your healthcare provider immediately for further evaluation.
Spigelia Anthelmia Whole has several significant drug interactions that must be managed carefully. It should never be taken with PDE5 inhibitors like Viagra or Cialis, as this can cause a life-threatening drop in blood pressure. It may also interact with other blood pressure medications, antidepressants, and certain herbal supplements like St. John's Wort. Because it is a 'whole' plant extract with multiple active compounds, the potential for interactions is higher than with single-chemical drugs. Always provide your doctor with a complete list of all medications and supplements you are currently taking.
Spigelia Anthelmia Whole is primarily available as a botanical extract or a homeopathic preparation rather than a traditional 'generic' pharmaceutical. However, because it is a natural substance, it is produced by various manufacturers under different brand names or as a non-branded bulk extract. The quality and concentration can vary significantly between different suppliers. It is important to use a high-quality, standardized product from a reputable source to ensure you are receiving a consistent dose. Your healthcare provider can recommend specific brands that meet the necessary regulatory and quality standards.